[HTML][HTML] Higher expression of circulating miR‑182 as a novel biomarker for breast cancer
MicroRNAs (miRNAs), present in the serum in a stable and reproducible manner, may be
used as biomarkers for various diseases. Few studies have previously investigated …
used as biomarkers for various diseases. Few studies have previously investigated …
[HTML][HTML] Reduced expression levels of let‑7c in human breast cancer patients
XX Li, SY Gao, PY Wang, X Zhou, YJ Li… - Oncology …, 2015 - spandidos-publications.com
Circulating microRNAs (miRNAs) are important in the diagnosis of a number of diseases,
since serum or plasma miRNAs are more stable compared with miRNA isolated from blood …
since serum or plasma miRNAs are more stable compared with miRNA isolated from blood …
Estrogen Induces c-myc Transcription by Binding to Upstream ERE Element in Promoter
Estrogen Receptor α (ERα) is reported to regulate the expression of many target genes by
binding to specific estrogen response elements (EREs) in their promoters. c-myc is known to …
binding to specific estrogen response elements (EREs) in their promoters. c-myc is known to …
Hypofractionated radiotherapy for breast cancers-preliminary results from a tertiary care center in eastern India
M Nandi, A Mahata, I Mallick, R Achari… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The standard radiotherapy (RT) fractionation practiced in India and worldwide
is 50Gy in 25 fractions over 5 weeks to the chest wall or whole breast followed by tumour …
is 50Gy in 25 fractions over 5 weeks to the chest wall or whole breast followed by tumour …
[HTML][HTML] Increased tumour infiltration of CD4+ and CD8+ T-lymphocytes in patients with triple negative breast cancer suggests susceptibility to immune therapy
B Sikandar, MA Qureshi, S Naseem… - Asian Pacific Journal …, 2017 - ncbi.nlm.nih.gov
Background: Patients with triple negative breast cancer (TNBC) have limited therapeutic
options, largely because the complex tumour environment is not well-characterized. These …
options, largely because the complex tumour environment is not well-characterized. These …
A cohort study investigating the role of Bisphenol A in the molecular pathogenesis of breast cancer
A Ishtiaq, MA Nasrullah, JS Khan, S Malik… - Journal of Cancer …, 2023 - Springer
Background Breast cancer is an abnormal division of breast cells. Bisphenol A (BPA), an
environmental toxicant, is identified as an emerging risk factor for breast cancer …
environmental toxicant, is identified as an emerging risk factor for breast cancer …
[HTML][HTML] Expression of the androgen receptor, pAkt, and pPTEN in breast cancer and their potential in prognostication
BACKGROUND Importance of androgen receptor (AR) as an independent prognostic
marker in Pakistani women with breast cancer (BCa) remains unexplored. Our aim was to …
marker in Pakistani women with breast cancer (BCa) remains unexplored. Our aim was to …
Correlation of Hormone Receptor and HER2/neu Expression with Clinicopathologic Parameters in Primary Breast Tumors
Background: Breast cancer (BC) is a major health issue worldwide as well as in Pakistan. All
women belonging to any race, ethnicity or lineage are in danger of develo** breast …
women belonging to any race, ethnicity or lineage are in danger of develo** breast …
Breast Cancer in Mosul: A Survival Analysis
THT Al-Saigh, SA Al-bayati… - Al Mustansiriyah …, 2020 - ajps.uomustansiriyah.edu.iq
Breast cancer is the most common cancer in women, and the major cause of death. This
study was conducted in order to make a descriptive study and survival analysis for breast …
study was conducted in order to make a descriptive study and survival analysis for breast …
[PDF][PDF] Invasive ductal carcinoma: correlation of immunophenotypic features with age
F Lateef, S Jamal, S Nasir, Z Jamil - J Coll Physicians Surg Pak, 2017 - jcpsp.pk
Objective: To evaluate the frequency of hormone receptors and Her2neu expression and
their correlation with age in patients of carcinoma breast. Study Design: Descriptive, cross …
their correlation with age in patients of carcinoma breast. Study Design: Descriptive, cross …